Disparities Exist in Outpatient Referrals for Opioid Use Disorder
By Lori Solomon HealthDay Reporter
MONDAY, July 7, 2025 -- Black patients presenting to the emergency department for an opioid overdose are less likely to receive outpatient referrals for opioid use disorder (OUD), according to a study published online July 2 in JAMA Network Open.
Siri Shastry, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined racial and ethnic disparities in treatment referral rates in emergency department patients with opioid overdose. The analysis included data from 10 hospital sites (1,683 patients) participating in the Toxicology Investigators Consortium Fentalog Study (Sept. 21, 2020, to Nov. 11, 2023).
The researchers found that 17.8 percent of patients presenting to the emergency department received a referral for outpatient treatment, 42.4 percent received a naloxone kit or prescription, and 8.4 percent received a buprenorphine prescription. Black patients had a decreased likelihood of outpatient treatment referral (adjusted odds ratio, 0.67) compared with White patients. Hospital admission was associated with an increased likelihood of outpatient treatment referral (adjusted odds ratio, 3.13). There was geographic variation noted for all primary and secondary outcomes.
"In this study, Black patients were less likely to receive outpatient referrals for OUD," the authors write. "These findings underscore the need for targeted interventions to address racial disparities in emergency department care for OUD, particularly in enhancing referral processes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Socioeconomic Deprivation Tied to Neurodegeneration in Combat Athletes
THURSDAY, Aug. 14, 2025 -- Athletes experiencing early-life socioeconomic disadvantage may have an increased risk for neurodegeneration from exposure to repetitive head injury...
ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes
THURSDAY, Aug. 14, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality...
2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type 1 Diabetes
THURSDAY, Aug. 14, 2025 -- From 2009 to 2023, there was an increase in use of diabetes technology and in glycemic control among youths and adults with type 1 diabetes (T1D)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.